Polar Asset Management Partners Inc. Trevi Therapeutics, Inc. Transaction History
Polar Asset Management Partners Inc.
- $4.67 Billion
- Q2 2025
A detailed history of Polar Asset Management Partners Inc. transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 74,300 shares of TRVI stock, worth $787,580. This represents 0.01% of its overall portfolio holdings.
Number of Shares
74,300
Previous 64,050
16.0%
Holding current value
$787,580
Previous $402,000
1.0%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TRVI
# of Institutions
164Shares Held
110MCall Options Held
1.07MPut Options Held
425K-
Nea Management Company, LLC Timonium, MD13.2MShares$140 Million6.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.3MShares$109 Million2.96% of portfolio
-
Rubric Capital Management LP New York, NY8.53MShares$90.4 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$56.4 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.49MShares$47.6 Million5.2% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $618M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...